首页 > 最新文献

Australian Prescriber最新文献

英文 中文
Faricimab for neovascular age-related macular degeneration and diabetic macular oedema. 治疗新生血管性老年黄斑变性和糖尿病性黄斑水肿的 Faricimab。
IF 2.7 Q2 PHARMACOLOGY & PHARMACY
Australian Prescriber
Pub Date : 2024-04-01 DOI: 10.18773/austprescr.2024.013
{"title":"Faricimab for neovascular age-related macular degeneration and diabetic macular oedema.","authors":"","doi":"10.18773/austprescr.2024.013","DOIUrl":"10.18773/austprescr.2024.013","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"47 2","pages":"66-67"},"PeriodicalIF":2.7,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11081741/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140913211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evidence-based management of menopause. 以证据为基础的更年期管理。
IF 2.7 Q2 PHARMACOLOGY & PHARMACY
Australian Prescriber
Pub Date : 2024-04-01 DOI: 10.18773/austprescr.2024.017
{"title":"Evidence-based management of menopause.","authors":"","doi":"10.18773/austprescr.2024.017","DOIUrl":"10.18773/austprescr.2024.017","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"47 2","pages":"43-45"},"PeriodicalIF":2.7,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11081740/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140913058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TGA Medicines Safety Update and Australian Prescriber-back to the future (take 2). 澳大利亚药品管理局《药品安全最新信息》和《澳大利亚开处方者--面向未来》（第二部分）。
IF 2.7 Q2 PHARMACOLOGY & PHARMACY
Australian Prescriber
Pub Date : 2024-02-01 DOI: 10.18773/austprescr.2024.003
{"title":"TGA <i>Medicines Safety Update</i> and <i>Australian Prescriber</i>-back to the future (take 2).","authors":"","doi":"10.18773/austprescr.2024.003","DOIUrl":"10.18773/austprescr.2024.003","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"47 1","pages":"29"},"PeriodicalIF":2.7,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10911834/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140040931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Andexanet alfa for reversal of direct factor Xa inhibitor anticoagulation. 用于逆转直接 Xa 因子抑制剂抗凝作用的 Andexanet alfa。
IF 2.7 Q2 PHARMACOLOGY & PHARMACY
Australian Prescriber
Pub Date : 2024-02-01 DOI: 10.18773/austprescr.2024.008
{"title":"Andexanet alfa for reversal of direct factor Xa inhibitor anticoagulation.","authors":"","doi":"10.18773/austprescr.2024.008","DOIUrl":"10.18773/austprescr.2024.008","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"47 1","pages":"31-32"},"PeriodicalIF":2.7,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10911831/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140040927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe liver injury following use of RAD-140, a selective androgen receptor modulator, for body building. 使用选择性雄激素受体调节剂 RAD-140 进行健美运动后出现严重肝损伤。
IF 2.7 Q2 PHARMACOLOGY & PHARMACY
Australian Prescriber
Pub Date : 2024-02-01 DOI: 10.18773/austprescr.2024.004
Varan Perananthan, Jacob George
{"title":"Severe liver injury following use of RAD-140, a selective androgen receptor modulator, for body building.","authors":"Varan Perananthan, Jacob George","doi":"10.18773/austprescr.2024.004","DOIUrl":"10.18773/austprescr.2024.004","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"47 1","pages":"26-28"},"PeriodicalIF":2.7,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10911832/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140040930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Morphine oral liquid availability. 吗啡口服液的可用性。
IF 2.7 Q2 PHARMACOLOGY & PHARMACY
Australian Prescriber
Pub Date : 2024-02-01 DOI: 10.18773/austprescr.2024.007
{"title":"Morphine oral liquid availability.","authors":"","doi":"10.18773/austprescr.2024.007","DOIUrl":"https://doi.org/10.18773/austprescr.2024.007","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"47 1","pages":"30"},"PeriodicalIF":2.7,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10911830/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140040929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Managing pre-existing diabetes prior to and during pregnancy. 在怀孕前和怀孕期间控制原有的糖尿病。
IF 3.4 Q2 PHARMACOLOGY & PHARMACY
Australian Prescriber
Pub Date : 2024-02-01 DOI: 10.18773/austprescr.2024.002
Leonie K Callaway, Fiona Britten

Women with pre-existing diabetes who are planning a pregnancy ideally should receive high-quality, multidisciplinary preconception care in a specialist centre; this has been shown to improve pregnancy outcomes. Optimising glycaemic management is essential prior to conception and throughout pregnancy and breastfeeding to minimise adverse events. Low-dose aspirin is recommended from 12 weeks gestation for prevention of pre-eclampsia. Breastfeeding is highly advantageous in women with pre-existing diabetes; women often need additional support with establishment and maintenance of breastfeeding. High-quality postpartum care and effective contraception are essential.

计划怀孕的原有糖尿病妇女最好在专科中心接受高质量、多学科的孕前护理；这已被证明可改善妊娠结局。在受孕前、整个孕期和哺乳期，优化血糖管理对减少不良事件至关重要。建议从妊娠 12 周开始服用小剂量阿司匹林，以预防先兆子痫。母乳喂养对患有糖尿病的妇女非常有利；妇女通常需要额外的支持来建立和维持母乳喂养。高质量的产后护理和有效的避孕措施至关重要。
{"title":"Managing pre-existing diabetes prior to and during pregnancy.","authors":"Leonie K Callaway, Fiona Britten","doi":"10.18773/austprescr.2024.002","DOIUrl":"10.18773/austprescr.2024.002","url":null,"abstract":"<p><p>Women with pre-existing diabetes who are planning a pregnancy ideally should receive high-quality, multidisciplinary preconception care in a specialist centre; this has been shown to improve pregnancy outcomes. Optimising glycaemic management is essential prior to conception and throughout pregnancy and breastfeeding to minimise adverse events. Low-dose aspirin is recommended from 12 weeks gestation for prevention of pre-eclampsia. Breastfeeding is highly advantageous in women with pre-existing diabetes; women often need additional support with establishment and maintenance of breastfeeding. High-quality postpartum care and effective contraception are essential.</p>","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"47 1","pages":"2-6"},"PeriodicalIF":3.4,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10911833/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140040928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Physical health monitoring for people with schizophrenia 精神分裂症患者的身体健康状况监测
IF 2.7 Q2 PHARMACOLOGY & PHARMACY
Australian Prescriber
Pub Date : 2023-12-12 DOI: 10.18773/austprescr.2023.024
David J Castle, Amy Li
{"title":"Physical health monitoring for people with schizophrenia","authors":"David J Castle, Amy Li","doi":"10.18773/austprescr.2023.024","DOIUrl":"https://doi.org/10.18773/austprescr.2023.024","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"14 6","pages":""},"PeriodicalIF":2.7,"publicationDate":"2023-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139007450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ongoing challenges of off-label prescribing 标示外处方的持续挑战
IF 2.7 Q2 PHARMACOLOGY & PHARMACY
Australian Prescriber
Pub Date : 2023-12-12 DOI: 10.18773/austprescr.2023.022
Richard O Day
{"title":"Ongoing challenges of off-label prescribing","authors":"Richard O Day","doi":"10.18773/austprescr.2023.022","DOIUrl":"https://doi.org/10.18773/austprescr.2023.022","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"50 14","pages":""},"PeriodicalIF":2.7,"publicationDate":"2023-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139007151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Latest News: Valediction: John Dowden 最新消息告别约翰-道登
IF 2.7 Q2 PHARMACOLOGY & PHARMACY
Australian Prescriber
Pub Date : 2023-12-12 DOI: 10.18773/austprescr.2023.021
{"title":"Latest News: Valediction: John Dowden","authors":"","doi":"10.18773/austprescr.2023.021","DOIUrl":"https://doi.org/10.18773/austprescr.2023.021","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"13 71","pages":""},"PeriodicalIF":2.7,"publicationDate":"2023-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139007638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
类型
全部 化学•材料 生命科学 医学 物理 工程技术 环境•农林 材料科学 地球科学 法学 管理学 化学 环境科学与生态学 计算机科学 教育学 经济学 农林科学 人文科学 生物学 数学 物理与天体物理 心理学 综合性期刊 其他 工业工程 理学 历史学 农学 文学 信息工程
数据库
全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley
期刊
Australian Prescriber
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们：info@booksci.cn
Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1